| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 11/19/2013 | US8586101 Bioresorbable bone mineral substitute comprising water-soluble X-ray contrast agent |
| 11/19/2013 | US8586096 Soy or lentil stabilized gold nanoparticles and method for making same |
| 11/19/2013 | US8586059 Cattle vaccines |
| 11/19/2013 | US8586022 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 11/19/2013 | US8586006 Organ-specific proteins and methods of their use |
| 11/19/2013 | US8586005 Ultrasound contrast agent dosage formulation |
| 11/19/2013 | CA2541385C Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
| 11/14/2013 | WO2013170085A1 A positron emission tomography probe to monitor selected sugar metabolism in vivo |
| 11/14/2013 | WO2013169932A2 Methods to detect a fungal cell |
| 11/14/2013 | WO2013168820A1 Anti-cxadr antibody |
| 11/14/2013 | WO2013168622A1 Imaging marker and utilization thereof |
| 11/14/2013 | WO2013167654A1 Ultrasound contact fluid |
| 11/14/2013 | US20130305396 Engineered human endosialin-expressing rodents |
| 11/14/2013 | US20130302258 Mri contrast agents |
| 11/14/2013 | US20130302256 Nanoparticulate manganese mri contrast agents |
| 11/14/2013 | US20130302255 Novel targeted paramagnetic contrast agent |
| 11/14/2013 | US20130302251 Embolic devices |
| 11/13/2013 | EP2661281A2 Hydrophobic molecule-induced branched polymer aggregates and their use |
| 11/13/2013 | EP2661259A2 Acoustically responsive particles with decreased cavitation threshold |
| 11/13/2013 | CN103391790A Method, composition and package for bowel cleansing |
| 11/13/2013 | CN103391789A Imaging agents |
| 11/13/2013 | CN103387955A Making method and use of non-human mammal B lymphocyte defect animal model |
| 11/13/2013 | CN103386139A Preparation method for medical gastroscope glue |
| 11/13/2013 | CN103386135A Preparation method of multifunctional medicine carrier integrating magnetism, fluorescence and thermosensitivity |
| 11/13/2013 | CN102516116B Low-osmotic-pressure triiodo-benzene compound contrast agent |
| 11/13/2013 | CN102336681B Triiodobenzene compound contrast agent |
| 11/13/2013 | CN102037097B Oleoylethanolamide based functional mesophases |
| 11/13/2013 | CN101912276B Method and system in imaging contrast infused tissue and blood vessels |
| 11/13/2013 | CN101511382B Selectively targeted antimicrobial peptides and the use thereof |
| 11/12/2013 | US8580231 Compositions and methods comprising magnetic resonance contrast agents |
| 11/12/2013 | US8580230 Materials and methods for MRI contrast agents and drug delivery |
| 11/12/2013 | US8580229 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 11/12/2013 | CA2623334C High-purity texaphyrin metal complexes |
| 11/12/2013 | CA2460049C Enhanced resolution of tumor metastasis |
| 11/12/2013 | CA2340673C Method for detection of biological factors in epidermis |
| 11/07/2013 | WO2013166431A1 Lipids that increase insulin sensitivity and methods of using the same |
| 11/07/2013 | WO2013164758A1 Fluorescent, spherical sophorolipid mesostructures for imaging and therapeutic applications |
| 11/07/2013 | WO2013009701A9 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| 11/07/2013 | US20130298263 Nucleic acid construct for expression of oxidative stress indicator and use thereof |
| 11/07/2013 | US20130295020 Radiopaque Embolic Particles |
| 11/07/2013 | US20130295019 Ligands and methods for labeling biomolecules in vivo |
| 11/07/2013 | US20130295018 Liquid preparation for oral administration used for ct colonography and composition for gastrointestinal radiography |
| 11/07/2013 | US20130295015 Optically-Controlled CNS Dysfunction |
| 11/07/2013 | US20130295014 Methods for treating and diagnosing blinding eye diseases |
| 11/07/2013 | US20130295013 Solid composition for the oral administration of dyes and diagnostic use thereof |
| 11/06/2013 | EP2660267A1 Degradable polymeric contrast agents for cancer diagnostic |
| 11/06/2013 | EP2659913A2 Method to identify p11 modulators |
| 11/06/2013 | EP2658896A2 Biocompatible agent for dispersing nanoparticles into an aqueous medium using mussel adhesive protein-mimetic polymer |
| 11/06/2013 | CN103382205A Bone-targeting zinc phthalocyanine and its preparation method and use |
| 11/06/2013 | CN102504015B Cardiovascular targeted small peptide MI-1 and application thereof |
| 11/06/2013 | CN102154209B Human osteosarcoma cell strain and application thereof |
| 11/06/2013 | CN101668546B Quantum theory-based continuous precision nmr/mri: method and apparatus |
| 11/05/2013 | US8575314 Antibody against oxidized LDL/β2GPI complex and use of the same |
| 11/05/2013 | US8575129 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
| 11/05/2013 | US8574828 Controlled platelet activation to monitor therapy of ADP antagonists |
| 11/05/2013 | US8574590 Lipoparticles comprising proteins, methods of making, and using the same |
| 11/05/2013 | US8574583 AAV capsid library and AAV capsid proteins |
| 11/05/2013 | US8574551 Compositions useful for reducing nephrotoxicity and methods of use thereof |
| 11/05/2013 | US8574550 Biocompatible polymeric contrast agents and radiopaque materials for medical services |
| 11/05/2013 | US8574549 Nanoparticle contrast agents for diagnostic imaging |
| 11/05/2013 | US8574547 Photoacoustic probes and methods of imaging |
| 11/05/2013 | CA2690395C Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 11/05/2013 | CA2492803C Oxime conjugates and methods for their formation and use |
| 11/05/2013 | CA2394015C Tweak receptor |
| 10/31/2013 | WO2013163321A1 Singlet oxygen-labile linkers and methods of production and use thereof |
| 10/31/2013 | WO2013162502A1 Tissue visualization for resection |
| 10/31/2013 | WO2013161693A1 Diagnostic agent and diagnostic method for irritable bowel syndrome induced by abnormal proliferation of enterobacteria |
| 10/31/2013 | WO2013160885A1 A nanosphere - histone acetyltransferase (hat) activator composition, process and methods thereof |
| 10/31/2013 | WO2013159185A1 Porphyrin-lipid stabilized nanoparticles for surface enhanced raman scattering based imaging |
| 10/31/2013 | WO2013131994A3 Coating for the diagnosis of inflammatory tissues in dental applications |
| 10/31/2013 | WO2013131993A3 Chewing gum for the diagnosis of inflammatory tissues in dental applications |
| 10/31/2013 | WO2013055899A3 Compositions useful in treating nephropathy and methods for preparation of same |
| 10/31/2013 | WO2002087500A3 Viral enzyme activated prototoxophores and use of same to treat viral infections |
| 10/31/2013 | US20130291132 Anf-rgc in-gene knock-out animal |
| 10/31/2013 | US20130289388 Post-biopsy cavity treatment implants and methods |
| 10/31/2013 | US20130289385 Deep brain stimulation of memory circuits in alzheimer's disease |
| 10/31/2013 | US20130287798 Uses of monoclonial antibody 8h9 |
| 10/31/2013 | US20130287702 Methods and compositions for the detection of cancer cells |
| 10/31/2013 | US20130287701 Method of detecting risk of cancer |
| 10/31/2013 | US20130287700 Compounds for the diagnosis of neurodegenerative disorders on the olfactory epithelium |
| 10/31/2013 | US20130287699 Luciferin Derivatives from Bicyclic Reactants and Aminothiol Derivatives and Methods of Use Thereof |
| 10/31/2013 | US20130287695 Chondrocyte-like cell, and method for producing same |
| 10/31/2013 | US20130287694 Animal model of anxiety and depression |
| 10/31/2013 | US20130287690 Solid composition for the oral administration of dyes and diagnostic use thereof |
| 10/30/2013 | EP2657243A1 L-Sugar Colon Cleansing Agent and Uses Thereof |
| 10/30/2013 | EP2656847A2 Conjugate for photodynamic diagnosis or therapy and method for preparing same |
| 10/30/2013 | EP2655318A1 Desalination of a composition comprising a contrast agent |
| 10/30/2013 | EP2654802A1 Chelate nanoemulsion for mri |
| 10/30/2013 | EP2654796A1 Agents for clearing biomolecules from circulation |
| 10/30/2013 | EP2654551A1 Photo-acoustic signal enhancement with microbubble-based contrast agents |
| 10/30/2013 | CN103379920A Nanoparticles loaded with chemotherapeutic antitumoral drug |
| 10/30/2013 | CN103379850A Photo-acoustic signal enhancement with microbubble-based contrast agents |
| 10/30/2013 | CN103374208A Gradient degradable polymeric material and preparation method thereof |
| 10/30/2013 | CN103372407A Preparation method of magnetic fluorescent composite nanospheres |
| 10/30/2013 | CN103372382A Preparation method and device of treatment type microbubble ultrasound contrast agent |
| 10/30/2013 | CN103372220A Pharmaceutical microsphere for embolization |
| 10/30/2013 | CN103372219A Buccal tablet placebo and preparation method therefor |
| 10/30/2013 | CN102379873B Acute general Parkinson's disease monkey model and medicament screening method thereof |
| 10/30/2013 | CN102276498B Contrast medium for triiodobenzene compound |
| 10/30/2013 | CN101991866B Nanometer gamma-Fe2O3 relaxation rate standard substance and preparation method thereof |